1921
Volume 95, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract

During an active surveillance study in school children in Medellin, we assessed the performance of two diagnostic strategies for dengue virus. A total of 41 patients with suspected dengue acute infection were evaluated. Diagnostic strategies consisted of one combining Panbio Dengue virus IgM and IgG Capture ELISAs (enzyme-linked immunosorbent assays) with reverse transcriptase polymerase chain reaction (RT-PCR) and another using a commercial rapid SD Bioline Dengue Duo (IgG/IgM + NS1 Ag) test. These two strategies were compared with the enzyme-linked immunospot microneutralization test (ELISPOT-MNT). The sensitivity and specificity were 53.9% and 80.0% for the combination of Panbio ELISAs and RT-PCR tests, and 30.8% and 73.3% for the SD Bioline Duo test, respectively. ELISPOT-MNT detected 16.4% additional cases and revealed the presence of neutralizing antibodies in all the acute samples, evidencing that they were all secondary infections. In contrast, Panbio and SD Dengue Duo rapid tests only classified 23.0% and 26.9% of the cases as secondary dengue infections, respectively. Cohen's kappa coefficient and McNemar's association tests demonstrated a significant disagreement between the two diagnostic strategies and ELISPOT-MNT. Overall, these results evidence the relatively poor performances of commercial assays for the diagnosis of acute and secondary dengue infections, compared with ELISPOT-MNT, and raise concern about the accuracy of these assays for the diagnostic of dengue in endemic areas.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.15-0492
2016-08-03
2017-11-19
Loading full text...

Full text loading...

/deliver/fulltext/14761645/95/2/315.html?itemId=/content/journals/10.4269/ajtmh.15-0492&mimeType=html&fmt=ahah

References

  1. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GRW, Simmons CP, Scott TW, Farrar JJ, Hay SI, , 2013. The global distribution and burden of dengue. Nature 496: 504507.[Crossref]
  2. World Health Organization (WHO), 2009. Dengue Guidelines for Diagnosis, Treatment, Prevention and Control, new edition. WHO. Available at: http://www.who.int/rpc/guidelines/9789241547871/en/. Accessed June 6, 2013.
  3. Instituto Nacional De Salud, 2013. Estadísticas Sivigila—Public. Available at: http://www.ins.gov.co/lineas-de-accion/Subdireccion-Vigilancia/sivigila/Estadsticas%20SIVIGILA/Forms/public.aspx. Accessed August 12, 2013.
  4. ViralZone, 2014. Flavivirus. Available at: http://viralzone.expasy.org/viralzone/all_by_species/24.html. Accessed December 9, 2014.
  5. Halstead SB, , 2008. Dengue virus—mosquito interactions. Annu Rev Entomol 53: 273291.[Crossref]
  6. Instituto Nacional De Salud, 2014. Vigilancia Rutinaria. Available at: http://www.ins.gov.co/lineas-de-accion/Subdireccion-Vigilancia/sivigila/Paginas/vigilancia-rutinaria.aspx.
  7. Zompi S, Santich BH, Beatty PR, Harris E, , 2012. Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells. J Immunol 188: 404416.[Crossref]
  8. Guzman MG, Jaenisch T, Gaczkowski R, Ty Hang VT, Sekaran SD, Kroeger A, Vazquez S, Ruiz D, Martinez E, Mercado JC, Balmaseda A, Harris E, Dimano E, Leano PSA, Yoksan S, Villegas E, Benduzu H, Villalobos I, Farrar J, Simmons CP, , 2010. Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis. PLoS Negl Trop Dis 4: e811.[Crossref]
  9. Wiwanitkit V, , 2012. The importance of accurate diagnosis of dengue fever. Future Virol 7: 5362.[Crossref]
  10. Falconar AKI, de Plata E, Romero-Vivas CME, , 2006. Altered enzyme-linked immunosorbent assay immunoglobulin M (IgM)/IgG optical density ratios can correctly classify all primary or secondary dengue virus infections 1 day after the onset of symptoms, when all of the viruses can be isolated. Clin Vaccine Immunol 13: 10441051.[Crossref]
  11. Shu P-Y, Chen L-K, Chang S-F, Yueh Y-Y, Chow L, Chien L-J, Chin C, Lin T-H, Huang J-H, , 2003. Comparison of capture immunoglobulin M (IgM) and IgG enzyme-linked immunosorbent assay (ELISA) and nonstructural protein NS1 serotype-specific IgG ELISA for differentiation of primary and secondary dengue virus infections. Clin Diagn Lab Immunol 10: 622630.
  12. Russell PK, Nisalak A, , 1967. Dengue virus identification by the plaque reduction neutralization test. J Immunol 99: 291296.
  13. World Health Organization (WHO) Department of Immunization, Vaccines and Biologicals, 2007. Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses. Available at: http://whqlibdoc.who.int/hq/2007/who_ivb_07.07_eng.pdf. Accessed December 9, 2014.
  14. Van Panhuis WG, Gibbons RV, Endy TP, Rothman AL, Srikiatkhachorn A, Nisalak A, Burke DS, Cummings DA, , 2010. Inferring the serotype of dengue virus infections based on pre- and post-infection neutralizing antibody titers. J Infect Dis 202: 10021010.[Crossref]
  15. Thomas SJ, Nisalak A, Anderson KB, Libraty DH, Kalayanarooj S, Vaughn DW, Putnak R, Gibbons RV, Jarman R, Endy TP, , 2009. Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: how alterations in assay conditions impact performance. Am J Trop Med Hyg 81: 825833.[Crossref]
  16. Liu L, Wen K, Li J, Hu D, Huang Y, Qiu L, Cai J, Che X, , 2012. Comparison of plaque- and enzyme-linked immunospot-based assays to measure the neutralizing activities of monoclonal antibodies specific to domain III of dengue virus envelope protein. Clin Vaccine Immunol 19: 7378.[Crossref]
  17. Restrepo BN, Piedrahita LD, Agudelo IY, Parra-Henao G, Osorio JE, , 2012. Frequency and clinical features of dengue infection in a schoolchildren cohort from Medellin, Colombia. J Trop Med 2012: 120496.[Crossref]
  18. Harris E, Roberts TG, Smith L, Selle J, Kramer LD, Valle S, Sandoval E, Balmaseda A, , 1998. Typing of dengue viruses in clinical specimens and mosquitoes by single-tube multiplex reverse transcriptase PCR. J Clin Microbiol 36: 26342639.
  19. Corbett KS, Katzelnick L, Tissera H, Amerasinghe A, de Silva AD, de Silva AM, , 2015. Preexisting neutralizing antibody responses distinguish clinically inapparent and apparent dengue virus infections in a Sri Lankan pediatric cohort. J Infect Dis 211: 590599.[Crossref]
  20. Montoya M, Gresh L, Mercado JC, Williams KL, Vargas MJ, Gutierrez G, Kuan G, Gordon A, Balmaseda A, Harris E, , 2013. Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year. PLoS Negl Trop Dis 7: e2357.[Crossref]
  21. Hunsperger EA, Yoksan S, Buchy P, Nguyen VC, Sekaran SD, Enria DA, Vazquez S, Cartozian E, Plegrino JL, Artsob H, Guzman MG, Olliaro P, Zwang J, Guillerm M, Kliks S, Halstead S, Peeling RW, Margolis HS, , 2014. Evaluation of commercially available diagnostic tests for the detection of dengue virus NS1 antigen and anti-dengue virus IgM antibody. PLoS Negl Trop Dis 8: e3171.[Crossref]
  22. Felix AC, Romano CM, Centrone C de C, Rodrigues CL, Villas-Boas L, Araújo ES, de Matos AM, Carvalho KI, Martelli CMT, Kallas ÈG, Pannuti CS, Levi JE, , 2012. Low sensitivity of NS1 protein tests evidenced during a dengue type 2 virus outbreak in Santos, Brazil, in 2010. Clin Vaccine Immunol 19: 19721976.[Crossref]
  23. Osorio L, Ramirez M, Bonelo A, Villar LA, Parra B, , 2010. Comparison of the diagnostic accuracy of commercial NS1-based diagnostic tests for early dengue infection. Virol J 7: 361.[Crossref]
  24. Andries A-C, Duong V, Ngan C, Ong S, Huy R, Sroin KK, Te V, Y B, Try PL, Buchy P, , 2012. Field evaluation and impact on clinical management of a rapid diagnostic kit that detects dengue NS1, IgM and IgG. PLoS Negl Trop Dis 6: e1993.[Crossref]
  25. Paula D, Oliveira S, da Fonseca BAL, , 2004. Dengue: a review of the laboratory tests a clinician must know to achieve a correct diagnosis. Braz J Infect Dis 8: 390398.[Crossref]
  26. Blacksell SD, Jarman RG, Gibbons RV, Tanganuchitcharnchai A, Mammen MP, Nisalak A, Kalayanarooj S, Bailey MS, Premaratna R, de Silva HJ, Day NPJ, Lalloo DG, , 2012. Comparison of seven commercial antigen and antibody enzyme-linked immunosorbent assays for detection of acute dengue infection. Clin Vaccine Immunol 19: 804810.[Crossref]
  27. Vickers IE, Harvey KM, Brown MG, Nelson K, DuCasse MB, Lindo JF, , 2015. The performance of the SD BIOLINE Dengue DUO® rapid immunochromatographic test kit for the detection of NS1 antigen, IgM and IgG antibodies during a dengue type 1 epidemic in Jamaica. J Biomed Sci 22: 55.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.15-0492
Loading
/content/journals/10.4269/ajtmh.15-0492
Loading

Data & Media loading...

  • Received : 02 Jul 2015
  • Accepted : 15 Apr 2016

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error